Selective tricuspidization and aortic cusp extension valvuloplasty: outcome analysis in infants and children

Anastasios C Polimenakos1, Shyam Sathanandam, Christopher Blair

  • 1Division of Pediatric Cardiovascular Surgery, The Heart Institute for Children at Advocate Hope Children's Hospital, Oak Lawn, Illinois, USA. anastasios_c_polimenakos@rush.edu

Insights

Aortic cusp extension valvuloplasty is a durable, nonreplacement strategy for children with aortic valve disease, offering good long-term freedom from aortic valve replacement (AVR). This technique facilitates left ventricular reverse remodeling in pediatric patients.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Cardiac Surgery

Background:

  • Emerging aortic cusp extension valvuloplasty techniques offer nonreplacement strategies for younger patients with aortic insufficiency or stenosis.
  • Analysis of outcomes after aortic cusp extension valvuloplasty in infants and children was performed.

Purpose of the Study:

  • To evaluate the outcomes of aortic cusp extension valvuloplasty in pediatric patients.
  • To assess long-term freedom from aortic valve replacement (AVR) and identify determinants of outcome.

Main Methods:

  • Aortic cusp extension valvuloplasty, including pericardial cusp extension and tricuspidization, was performed on 78 patients younger than 10 years between 1987 and 2008.
  • Patients included those with bicuspid aortic valve, congenital aortic valve stenosis, or aortic insufficiency/stenosis, with some having prior valvuloplasty.
  • Median follow-up was 12.4 years, analyzing freedom from AVR.

Main Results:

  • No early or late deaths occurred.
  • Actuarial freedom from aortic valve replacement (AVR) at 1, 5, and 10 years was 97.3%, 71.3%, and 55.6%, respectively.
  • Left ventricular reverse remodeling was observed post-procedure.

Conclusions:

  • Aortic cusp extension valvuloplasty with tricuspidization provides satisfactory long-term durability and freedom from AVR in infants and children.
  • This technique is a reliable and effective approach for managing congenital or acquired abnormal aortic valves in pediatric populations.
  • The procedure allows for left ventricular reverse remodeling.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...